Dr. David Ali, CEO and Executive Director: David took up the position of CEO and executive Director in June 2024, following years of experience within the pharmaceutical industry. David holds a PhD in Pharmacokinetics and is a published researcher. He has presented at international conferences and worked in drug discovery, clinical project management, clinical pathology, business development and operations at senior levels. He has led local and international clinical trials across all phases and has spent the last 10 years developing medico-commercial strategy to facilitate the launch of new products into the Australian market.

David has also spent several years in the animal health sector, where he engaged with key opinion leaders (KOLs) to build relationships and facilitate the success of new products. Given Memphasys’s focus on both human and animal fertility, his combined experience in human pharmaceuticals and animal health equips him with a comprehensive understanding and a strong foundation to further develop the Memphasys business, brand and commercialise the growing pipeline.